Course outline
Module 1
Module 1: Introduction to Senolytics
Introduction to Senolytics
Knowledge check
Q1. What are senescent cells commonly referred to as?
- A. Healthy cells
- B. Zombie cells ✓
- C. Stem cells
- D. Mitotic cells
Why: Senescent cells are often called zombie cells because they are damaged and do not function properly but remain metabolically active.
Q2. Which of the following is a characteristic of senescent cells?
- A. They divide rapidly
- B. They secrete pro-inflammatory factors ✓
- C. They promote tissue regeneration
- D. They are highly mobile
Why: Senescent cells secrete pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP), which can harm surrounding tissues.
Q3. What is the primary goal of senolytics?
- A. To increase cell division
- B. To clear senescent cells ✓
- C. To promote apoptosis in healthy cells
- D. To enhance mitochondrial function
Why: Senolytics are drugs designed to selectively eliminate senescent cells, thereby reducing their harmful effects on the body.
Q4. Which of the following is a potential benefit of senolytics?
- A. Increased aging
- B. Improved tissue function ✓
- C. Reduced cell proliferation
- D. Increased inflammation
Why: By removing senescent cells, senolytics can improve tissue function and potentially slow down the aging process.
Q5. What is the main reason senescent cells accumulate with age?
- A. They are more active
- B. They are more numerous ✓
- D. They divide more frequently
Why: As we age, the immune system becomes less efficient at clearing senescent cells, leading to their accumulation in tissues.
Module 2
Module 2: The Biology of Zombie Cells
The Biology of Zombie Cells
Knowledge check
Q1. What are senescent cells commonly referred to as in the context of senolytics?
- A. Healthy cells
- B. Zombie cells ✓
- C. Stem cells
- D. Cancer cells
Why: Senescent cells are often called zombie cells because they are damaged, non-dividing cells that persist in the body and can cause harm.
Q2. Which of the following is a primary function of senescent cells?
- A. Promoting tissue regeneration
- B. Aiding in wound healing
- C. Secretion of pro-inflammatory factors ✓
- D. Producing energy for the body
Why: Senescent cells secrete pro-inflammatory factors, which can lead to chronic inflammation and tissue damage.
Q3. What is one of the key characteristics of senescent cells?
- A. High metabolic activity
- B. Ability to divide indefinitely
- C. Cell cycle arrest ✓
- D. Increased production of growth factors
Why: A key characteristic of senescent cells is that they are arrested in the cell cycle and can no longer divide.
Q4. Which of the following is a consequence of the accumulation of senescent cells?
- A. Improved immune function
- B. Enhanced tissue repair
- C. Age-related diseases ✓
- D. Increased lifespan
Why: Accumulation of senescent cells is associated with age-related diseases such as osteoarthritis and cardiovascular disease.
Q5. What is the primary goal of senolytic therapies?
- A. To increase the number of senescent cells
- B. To eliminate senescent cells ✓
- C. To transform senescent cells into healthy cells
- D. To promote the division of senescent cells
Why: The primary goal of senolytic therapies is to selectively eliminate senescent cells from the body.
Module 3
Module 3: Mechanisms of Cellular Senescence
Mechanisms of Cellular Senescence
Knowledge check
Q1. What is the primary function of p16INK4a in cellular senescence?
- A. Promoting cell division
- B. Inhibiting cell cycle progression ✓
- C. Enhancing mitochondrial function
- D. Stimulating autophagy
Why: p16INK4a is a cyclin-dependent kinase inhibitor that plays a key role in arresting the cell cycle, which is a hallmark of senescent cells.
Q2. Which of the following is a common characteristic of senescent cells?
- A. Increased metabolic activity
- B. Reduced mitochondrial function ✓
- C. Enhanced DNA repair
- D. Increased telomere length
Why: Senescent cells often exhibit reduced mitochondrial function, which contributes to their metabolic dysfunction and secretion of pro-inflammatory factors.
Q3. What is the role of SASP (Senescence-Associated Secretory Phenotype) in aging?
- A. Promotes tissue regeneration
- B. Contributes to chronic inflammation ✓
- C. Enhances stem cell function
- D. Reduces oxidative stress
Why: SASP is characterized by the secretion of pro-inflammatory cytokines and other factors that contribute to chronic inflammation and tissue dysfunction during aging.
Q4. Which of the following is a key driver of cellular senescence related to DNA damage?
- A. Telomere shortening ✓
- B. Increased mitochondrial biogenesis
- C. Enhanced protein synthesis
- D. Reduced lipid accumulation
Why: Telomere shortening is a major driver of cellular senescence, as it leads to DNA damage and the activation of DNA damage response pathways.
Q5. What is the main function of the tumor suppressor p53 in the context of cellular senescence?
- A. Promoting cell proliferation
- B. Inducing apoptosis ✓
- C. Inhibiting DNA repair
- D. Activating cell cycle progression
Why: p53 is a critical tumor suppressor that can induce apoptosis or cellular senescence in response to DNA damage or other stress signals.
Module 4
Module 4: Senolytic Drugs and Therapies
Senolytic Drugs and Therapies
Knowledge check
Q1. What are senolytic drugs primarily designed to target?
- A. Mitochondria
- B. Senescent cells ✓
- C. Stem cells
- D. Neurons
Why: Senolytic drugs are specifically designed to target and eliminate senescent cells, which are aged cells that no longer function properly and can cause harm to surrounding tissues.
Q2. Which of the following is a known senolytic drug?
- A. Aspirin
- B. Quercetin ✓
- C. Ibuprofen
- D. Paracetamol
Why: Quercetin is a flavonoid that has been identified as a potential senolytic agent, capable of inducing apoptosis in senescent cells.
Q3. What is a key characteristic of senescent cells that makes them a target for senolytic therapies?
- A. They divide rapidly
- B. They secrete pro-inflammatory factors ✓
- C. They are highly mobile
- D. They produce more energy
Why: Senescent cells secrete a variety of pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP), which can contribute to aging and age-related diseases.
Q4. Which of the following is a benefit of senolytic therapies?
- A. Increased cancer risk
- B. Improved tissue function ✓
- C. Reduced metabolism
- D. Increased inflammation
Why: Senolytic therapies can improve tissue function by removing senescent cells, which accumulate with age and contribute to tissue dysfunction and age-related diseases.
Q5. What is a common mechanism of action for senolytic drugs?
- A. Inhibiting DNA replication
- B. Inducing apoptosis in senescent cells ✓
- C. Blocking protein synthesis
- D. Enhancing mitochondrial function
Why: A common mechanism of action for senolytic drugs is inducing apoptosis in senescent cells, thereby eliminating these harmful cells from the body.
Module 5
Module 5: Senolytics in Aging and Disease
Senolytics in Aging and Disease
Knowledge check
Q1. What are senescent cells commonly referred to as in the context of aging?
- A. Healthy cells
- B. Zombie cells ✓
- C. Stem cells
- D. Mitochondria
Why: Senescent cells are often called 'zombie cells' because they are damaged and no longer function properly, yet they remain metabolically active and can harm surrounding cells.
Q2. Which of the following is a potential benefit of senolytics?
- A. Increased inflammation
- B. Promotion of cellular aging
- C. Reduction of age-related diseases ✓
- D. Inhibition of cell division
Why: Senolytics help remove senescent cells, which can reduce the risk of age-related diseases such as arthritis, heart disease, and diabetes.
Q3. What is the primary mechanism by which senolytics work?
- A. Promoting DNA replication
- B. Inducing apoptosis in senescent cells ✓
- C. Enhancing mitochondrial function
- D. Increasing telomere length
Why: Senolytics work by inducing apoptosis (programmed cell death) in senescent cells, thereby eliminating them from the body.
Q4. Which of the following is a known senolytic compound?
- A. Resveratrol
- B. Quercetin ✓
- C. Vitamin C
- D. Omega-3 fatty acids
Why: Quercetin is a flavonoid that has been identified as a potential senolytic compound due to its ability to selectively kill senescent cells.
Q5. What is a common characteristic of senescent cells that makes them harmful?
- A. They divide rapidly
- B. They secrete pro-inflammatory factors ✓
- C. They produce more energy
- D. They increase tissue regeneration
Why: Senescent cells secrete pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP), which can damage surrounding tissues and contribute to aging and disease.
Module 6
Module 6: Measuring Senescence in the Body
Measuring Senescence in the Body
Knowledge check
Q1. Which of the following is a common marker used to measure cellular senescence?
- A. p16INK4a ✓
- B. β-actin
- C. Albumin
- D. Collagen
Why: p16INK4a is a well-established marker of cellular senescence, commonly used in research to identify senescent cells.
Q2. What technique is frequently used to detect senescent cells in tissues?
- A. PCR
- B. ELISA
- C. Immunohistochemistry ✓
- D. Western blot
Why: Immunohistochemistry is a common technique used to visualize and detect senescent cells in tissues by using specific antibodies.
Q3. Which of the following is a function of senescent cells in the body?
- A. Promote tissue regeneration
- B. Enhance immune response
- C. Contribute to chronic inflammation ✓
- D. Accelerate cell division
Why: Senescent cells are known to secrete pro-inflammatory factors, contributing to chronic inflammation and age-related diseases.
Q4. Which of the following is a limitation of using senescence-associated β-galactosidase (SA-β-gal) as a marker?
- A. It is highly specific
- B. It is not easily detectable
- C. It can be active in non-senescent cells ✓
- D. It is only found in senescent cells
Why: SA-β-gal can be active in some non-senescent cells, making it less specific as a marker for senescence.
Q5. What is a primary challenge in measuring senescence in vivo?
- A. Lack of markers
- B. Difficulty in isolating cells
- C. Variability in tissue sampling
- D. All of the above ✓
Why: Measuring senescence in vivo is challenging due to the lack of specific markers, difficulty in isolating cells, and variability in tissue sampling methods.
Module 7
Module 7: Future Directions in Senolytic Research
Future Directions in Senolytic Research
Knowledge check
Q1. What is a primary goal of future senolytic research?
- A. To increase the number of senescent cells
- B. To develop more targeted and effective senolytic therapies ✓
- C. To eliminate all cells in the body
- D. To reverse aging completely
Why: Future research aims to refine and improve senolytic therapies to make them more specific and effective.
Q2. Which of the following is a potential challenge in developing senolytic drugs?
- A. They are too effective
- B. They may cause unintended side effects by targeting healthy cells ✓
- C. They are too expensive to produce
- D. They are not needed in research
Why: A major challenge is ensuring that senolytic drugs target only senescent cells without harming healthy ones.
Q3. What role do animal models play in senolytic research?
- A. They are not useful for research
- B. They help researchers understand the effects of senolytics in living organisms ✓
- C. They only slow down the research process
- D. They are used to increase the cost of research
Why: Animal models are essential for studying how senolytics work in complex biological systems.
Q4. Which of the following is a possible future application of senolytics?
- A. To treat only young people
- B. To improve the quality of life in older adults ✓
- C. To prevent all diseases
- D. To increase lifespan without any benefits
Why: Senolytics may help improve health and quality of life in older adults by reducing the burden of senescent cells.
Q5. What is a key area of interest in future senolytic research related to the immune system?
- A. To weaken the immune system
- B. To enhance the immune system's ability to clear senescent cells ✓
- C. To ignore the immune system
- D. To make the immune system inactive
Why: Future research is exploring ways to boost the immune system's role in clearing senescent cells naturally.